SGX Pharmaceuticals, INC.
SEC CIK 1125603 · sgxp · last insider filing 2008-08-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Bock Louis C | Director | filed 2006 - 2008 |
| Eastham Karin | Director | filed 2006 - 2008 |
| Grey Michael G | Director · President and CEO | filed 2006 - 2008 |
| Henney Christopher S | Director | filed 2006 - 2008 |
| Turner Joseph L | Director | filed 2007 - 2008 |
| Formela Jean Francois | Director | filed 2006 - 2007 |
| Lathi Vijay K | Director · President Chief VP | filed 2006 - 2007 |
| Papadopoulos Stelios | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Burley Stephen | Chief Scientific Ofc, SVP,Rsch | filed 2006 - 2008 |
| North Annette | VP, Legal and Corporate Sec | filed 2006 - 2008 |
| Myers W Todd | Chief Financial Officer | filed 2006 - 2008 |
| Reich Siegfried | Vice President, Drug Discovery | filed 2006 - 2008 |
| Rugg Terence Anthony | VP, Chief Medical Officer | filed 2006 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.